Tag: la jolla

April 20, 2016

OncBioMune Enters Joint Venture, Preparation for Phase 2 Trial of Novel Cancer Vaccine for Prostate Cancer Underway

OncBioMune Pharmaceuticals (OTCMKTS:OBMP) announced the execution of the contract to form a Joint Venture with Vitel Laboratorios S.A. de C.V....
April 12, 2016

vTv Therapeutics Announces Presentations on its Diabetes Product Candidates TTP273 and TTP399 at the Keystone Symposia on New Therapeutics for Diabetes and Obesity

HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally...
April 12, 2016

OncBioMune Receives Notice of Patent Allowance for Cancer Vaccine ProscaVax in Hong Kong

OncBioMune Pharmaceuticals (OTCMKTS:OBMP) announced that the Company has received a Notice of Allowance for a patent on ProscaVax®, OncBioMune's cancer...